ArticleCureus2025
Listeria monocytogenes Infective Endocarditis With Concurrent Bacterial Meningitis and Systemic Embolization: A Case Report and Literature Review.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Inappropriate Antimicrobial Regimen Leading to RecurrentInfection and drug resistance · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Listeria monocytogenes is an uncommon cause of infective endocarditis (IE), and the concurrent occurrence of Listeria IE with bacterial meningitis and systemic septic embolization is exceedingly rare. We report the case of a 74-year-old man who presented with fever and altered mental status and was found to have L. monocytogenes IE complicated by concurrent meningitis and multiple septic emboli, including cerebral infarcts, a splenic infarct, and hepatic microabscesses. Blood and cerebrospinal fluid cultures grew L. monocytogenes, confirming the diagnosis. He was treated with high-dose intravenous ampicillin plus gentamicin, as L. monocytogenes is intrinsically resistant to cephalosporins and the combination of an aminopenicillin with an aminoglycoside is the treatment of choice. The patient improved with therapy and completed a six-week course of antibiotics, achieving a favorable outcome. This case highlights the importance of rapid diagnosis and timely initiation of targeted antimicrobial therapy, as early treatment with ampicillin and gentamicin remains crucial for patient recovery and for reducing the high mortality associated with this rare but life-threatening infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.